Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats

Chronic leptin administration at pharmacologic doses normalizes food intake and body weight in streptozotocin (STZ)-diabetic rats. We examined the metabolic effects of acute partial physiological leptin restoration in STZ-diabetic rats by using subcutaneous osmotic mini pumps. Groups: (1) Rats infus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolism, clinical and experimental clinical and experimental, 2004-12, Vol.53 (12), p.1558-1564
Hauptverfasser: Akirav, Eitan M., Chan, Owen, Inouye, Karen, Riddell, Michael C., Matthews, Stephen G., Vranic, Mladen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1564
container_issue 12
container_start_page 1558
container_title Metabolism, clinical and experimental
container_volume 53
creator Akirav, Eitan M.
Chan, Owen
Inouye, Karen
Riddell, Michael C.
Matthews, Stephen G.
Vranic, Mladen
description Chronic leptin administration at pharmacologic doses normalizes food intake and body weight in streptozotocin (STZ)-diabetic rats. We examined the metabolic effects of acute partial physiological leptin restoration in STZ-diabetic rats by using subcutaneous osmotic mini pumps. Groups: (1) Rats infused with vehicle (DV); (2) rats infused with recombinant murine methionine leptin (DL) at 4.5 μg · (kg body weight · d)−1; (3)pair-fed rats (DP) given a food ration matching that consumed by the DL group. A fourth group of nondiabetic, normal (N) rats was also studied to assess normal metabolic efficiency, hypothalamic-pituitary-adrenal (HPA) activity and sympathoadrenal activity. Following leptin infusion, food consumption by DL rats was significantly lower than in DV rats. Paradoxically, despite a similar food intake to that of the DP group, which demonstrated a 40% reduction in body mass, DL rats increased their initial body weight by ∼20% (P < .05). Plasma corticosterone and ACTH concentrations were elevated by 2-fold to 3-fold in DL versus N, DP, and DV rats. In the pars distalis, glucocorticoid receptor (GR) mRNA levels were significantly higher in DL and DP rats compared with N and DV rats. Our results suggest that partial restoration of physiologic leptin: (1) successfully reduces hyperphagia while allowing body weight gain in STZ-diabetic rats; (2) increases corticosterone levels in STZ-diabetic rats, which may in turn counteract the anorexic effects of diabetes; and (3) is associated with increased pituitary GR mRNA levels, despite elevated corticosterone levels, suggesting that leptin may interfere with the negative feedback regulation of the HPA axis.
doi_str_mv 10.1016/j.metabol.2004.06.024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67107445</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026049504002793</els_id><sourcerecordid>67107445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-9cbd8c4f40f4af74956b8f482a517d8d80d4d18386d4cb5ae6ec73ec3446f59d3</originalsourceid><addsrcrecordid>eNqFkc2O1DAQhCMEYpeFRwD5ArcM7cRxMieEVvxJK8EBzlbH7kx6lMTB9uxqeBSeFo9mpD1ysix9Vd3VVRSvJWwkSP1-v5kpYe-nTQWgNqA3UKknxbVs6qrsNMDT4hqg0iWobXNVvIhxDwBt2-nnxZVsGl0pgOvi7w8MiXESE62JFxEoJh8wsV8ELzYQRopiPK4-jTjhzLZcOR04YTiW6AItWYs28T2no3gYeSLheOaF48jLTjwQ78YkJh-jwMWdnCisI-4Ys7-IKeS5_o9P3uavY-wpsRV5g_iyeDbgFOnV5b0pfn3-9PP2a3n3_cu32493pa23MpVb27vOqkHBoHBoc1rdd4PqKmxk6zrXgVNOdnWnnbJ9g6TJtjXZWik9NFtX3xTvzr5r8L8POb-ZOVqaJlzIH6LRrYRWqSaDzRm0IccJNJg18JwPYSSYUylmby6lmFMpBrTJpWTdm8uAQz-Te1RdWsjA2wuA0eI0BFwsx0dO162s6zZzH84c5XPcMwUTLdNiyXEgm4zz_J9V_gHtDbM3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67107445</pqid></control><display><type>article</type><title>Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Akirav, Eitan M. ; Chan, Owen ; Inouye, Karen ; Riddell, Michael C. ; Matthews, Stephen G. ; Vranic, Mladen</creator><creatorcontrib>Akirav, Eitan M. ; Chan, Owen ; Inouye, Karen ; Riddell, Michael C. ; Matthews, Stephen G. ; Vranic, Mladen</creatorcontrib><description>Chronic leptin administration at pharmacologic doses normalizes food intake and body weight in streptozotocin (STZ)-diabetic rats. We examined the metabolic effects of acute partial physiological leptin restoration in STZ-diabetic rats by using subcutaneous osmotic mini pumps. Groups: (1) Rats infused with vehicle (DV); (2) rats infused with recombinant murine methionine leptin (DL) at 4.5 μg · (kg body weight · d)−1; (3)pair-fed rats (DP) given a food ration matching that consumed by the DL group. A fourth group of nondiabetic, normal (N) rats was also studied to assess normal metabolic efficiency, hypothalamic-pituitary-adrenal (HPA) activity and sympathoadrenal activity. Following leptin infusion, food consumption by DL rats was significantly lower than in DV rats. Paradoxically, despite a similar food intake to that of the DP group, which demonstrated a 40% reduction in body mass, DL rats increased their initial body weight by ∼20% (P &lt; .05). Plasma corticosterone and ACTH concentrations were elevated by 2-fold to 3-fold in DL versus N, DP, and DV rats. In the pars distalis, glucocorticoid receptor (GR) mRNA levels were significantly higher in DL and DP rats compared with N and DV rats. Our results suggest that partial restoration of physiologic leptin: (1) successfully reduces hyperphagia while allowing body weight gain in STZ-diabetic rats; (2) increases corticosterone levels in STZ-diabetic rats, which may in turn counteract the anorexic effects of diabetes; and (3) is associated with increased pituitary GR mRNA levels, despite elevated corticosterone levels, suggesting that leptin may interfere with the negative feedback regulation of the HPA axis.</description><identifier>ISSN: 0026-0495</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/j.metabol.2004.06.024</identifier><identifier>PMID: 15562400</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenocorticotropic Hormone - blood ; Animals ; Biological and medical sciences ; Blood Glucose ; Body Weight - drug effects ; Corticosterone - blood ; Diabetes Mellitus, Experimental - blood ; Diabetes Mellitus, Experimental - complications ; Diabetes Mellitus, Experimental - metabolism ; Diabetes. Impaired glucose tolerance ; Eating - drug effects ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Epinephrine - blood ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Hyperphagia - blood ; Hyperphagia - drug therapy ; Hyperphagia - etiology ; Hypothalamo-Hypophyseal System - drug effects ; Hypothalamo-Hypophyseal System - metabolism ; Insulin - blood ; Leptin - pharmacology ; Male ; Medical sciences ; Mice ; Norepinephrine - blood ; Pituitary-Adrenal System - drug effects ; Pituitary-Adrenal System - metabolism ; Pro-Opiomelanocortin - biosynthesis ; Rats ; Rats, Sprague-Dawley ; Receptors, Glucocorticoid - biosynthesis ; Recombinant Proteins - pharmacology ; RNA, Messenger - biosynthesis</subject><ispartof>Metabolism, clinical and experimental, 2004-12, Vol.53 (12), p.1558-1564</ispartof><rights>2004 Elsevier Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-9cbd8c4f40f4af74956b8f482a517d8d80d4d18386d4cb5ae6ec73ec3446f59d3</citedby><cites>FETCH-LOGICAL-c391t-9cbd8c4f40f4af74956b8f482a517d8d80d4d18386d4cb5ae6ec73ec3446f59d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.metabol.2004.06.024$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,46004</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16371337$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15562400$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akirav, Eitan M.</creatorcontrib><creatorcontrib>Chan, Owen</creatorcontrib><creatorcontrib>Inouye, Karen</creatorcontrib><creatorcontrib>Riddell, Michael C.</creatorcontrib><creatorcontrib>Matthews, Stephen G.</creatorcontrib><creatorcontrib>Vranic, Mladen</creatorcontrib><title>Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>Chronic leptin administration at pharmacologic doses normalizes food intake and body weight in streptozotocin (STZ)-diabetic rats. We examined the metabolic effects of acute partial physiological leptin restoration in STZ-diabetic rats by using subcutaneous osmotic mini pumps. Groups: (1) Rats infused with vehicle (DV); (2) rats infused with recombinant murine methionine leptin (DL) at 4.5 μg · (kg body weight · d)−1; (3)pair-fed rats (DP) given a food ration matching that consumed by the DL group. A fourth group of nondiabetic, normal (N) rats was also studied to assess normal metabolic efficiency, hypothalamic-pituitary-adrenal (HPA) activity and sympathoadrenal activity. Following leptin infusion, food consumption by DL rats was significantly lower than in DV rats. Paradoxically, despite a similar food intake to that of the DP group, which demonstrated a 40% reduction in body mass, DL rats increased their initial body weight by ∼20% (P &lt; .05). Plasma corticosterone and ACTH concentrations were elevated by 2-fold to 3-fold in DL versus N, DP, and DV rats. In the pars distalis, glucocorticoid receptor (GR) mRNA levels were significantly higher in DL and DP rats compared with N and DV rats. Our results suggest that partial restoration of physiologic leptin: (1) successfully reduces hyperphagia while allowing body weight gain in STZ-diabetic rats; (2) increases corticosterone levels in STZ-diabetic rats, which may in turn counteract the anorexic effects of diabetes; and (3) is associated with increased pituitary GR mRNA levels, despite elevated corticosterone levels, suggesting that leptin may interfere with the negative feedback regulation of the HPA axis.</description><subject>Adrenocorticotropic Hormone - blood</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose</subject><subject>Body Weight - drug effects</subject><subject>Corticosterone - blood</subject><subject>Diabetes Mellitus, Experimental - blood</subject><subject>Diabetes Mellitus, Experimental - complications</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Eating - drug effects</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Epinephrine - blood</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Hyperphagia - blood</subject><subject>Hyperphagia - drug therapy</subject><subject>Hyperphagia - etiology</subject><subject>Hypothalamo-Hypophyseal System - drug effects</subject><subject>Hypothalamo-Hypophyseal System - metabolism</subject><subject>Insulin - blood</subject><subject>Leptin - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Norepinephrine - blood</subject><subject>Pituitary-Adrenal System - drug effects</subject><subject>Pituitary-Adrenal System - metabolism</subject><subject>Pro-Opiomelanocortin - biosynthesis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Glucocorticoid - biosynthesis</subject><subject>Recombinant Proteins - pharmacology</subject><subject>RNA, Messenger - biosynthesis</subject><issn>0026-0495</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2O1DAQhCMEYpeFRwD5ArcM7cRxMieEVvxJK8EBzlbH7kx6lMTB9uxqeBSeFo9mpD1ysix9Vd3VVRSvJWwkSP1-v5kpYe-nTQWgNqA3UKknxbVs6qrsNMDT4hqg0iWobXNVvIhxDwBt2-nnxZVsGl0pgOvi7w8MiXESE62JFxEoJh8wsV8ELzYQRopiPK4-jTjhzLZcOR04YTiW6AItWYs28T2no3gYeSLheOaF48jLTjwQ78YkJh-jwMWdnCisI-4Ys7-IKeS5_o9P3uavY-wpsRV5g_iyeDbgFOnV5b0pfn3-9PP2a3n3_cu32493pa23MpVb27vOqkHBoHBoc1rdd4PqKmxk6zrXgVNOdnWnnbJ9g6TJtjXZWik9NFtX3xTvzr5r8L8POb-ZOVqaJlzIH6LRrYRWqSaDzRm0IccJNJg18JwPYSSYUylmby6lmFMpBrTJpWTdm8uAQz-Te1RdWsjA2wuA0eI0BFwsx0dO162s6zZzH84c5XPcMwUTLdNiyXEgm4zz_J9V_gHtDbM3</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Akirav, Eitan M.</creator><creator>Chan, Owen</creator><creator>Inouye, Karen</creator><creator>Riddell, Michael C.</creator><creator>Matthews, Stephen G.</creator><creator>Vranic, Mladen</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats</title><author>Akirav, Eitan M. ; Chan, Owen ; Inouye, Karen ; Riddell, Michael C. ; Matthews, Stephen G. ; Vranic, Mladen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-9cbd8c4f40f4af74956b8f482a517d8d80d4d18386d4cb5ae6ec73ec3446f59d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adrenocorticotropic Hormone - blood</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose</topic><topic>Body Weight - drug effects</topic><topic>Corticosterone - blood</topic><topic>Diabetes Mellitus, Experimental - blood</topic><topic>Diabetes Mellitus, Experimental - complications</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Eating - drug effects</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Epinephrine - blood</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Hyperphagia - blood</topic><topic>Hyperphagia - drug therapy</topic><topic>Hyperphagia - etiology</topic><topic>Hypothalamo-Hypophyseal System - drug effects</topic><topic>Hypothalamo-Hypophyseal System - metabolism</topic><topic>Insulin - blood</topic><topic>Leptin - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Norepinephrine - blood</topic><topic>Pituitary-Adrenal System - drug effects</topic><topic>Pituitary-Adrenal System - metabolism</topic><topic>Pro-Opiomelanocortin - biosynthesis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Glucocorticoid - biosynthesis</topic><topic>Recombinant Proteins - pharmacology</topic><topic>RNA, Messenger - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akirav, Eitan M.</creatorcontrib><creatorcontrib>Chan, Owen</creatorcontrib><creatorcontrib>Inouye, Karen</creatorcontrib><creatorcontrib>Riddell, Michael C.</creatorcontrib><creatorcontrib>Matthews, Stephen G.</creatorcontrib><creatorcontrib>Vranic, Mladen</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akirav, Eitan M.</au><au>Chan, Owen</au><au>Inouye, Karen</au><au>Riddell, Michael C.</au><au>Matthews, Stephen G.</au><au>Vranic, Mladen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>53</volume><issue>12</issue><spage>1558</spage><epage>1564</epage><pages>1558-1564</pages><issn>0026-0495</issn><eissn>1532-8600</eissn><abstract>Chronic leptin administration at pharmacologic doses normalizes food intake and body weight in streptozotocin (STZ)-diabetic rats. We examined the metabolic effects of acute partial physiological leptin restoration in STZ-diabetic rats by using subcutaneous osmotic mini pumps. Groups: (1) Rats infused with vehicle (DV); (2) rats infused with recombinant murine methionine leptin (DL) at 4.5 μg · (kg body weight · d)−1; (3)pair-fed rats (DP) given a food ration matching that consumed by the DL group. A fourth group of nondiabetic, normal (N) rats was also studied to assess normal metabolic efficiency, hypothalamic-pituitary-adrenal (HPA) activity and sympathoadrenal activity. Following leptin infusion, food consumption by DL rats was significantly lower than in DV rats. Paradoxically, despite a similar food intake to that of the DP group, which demonstrated a 40% reduction in body mass, DL rats increased their initial body weight by ∼20% (P &lt; .05). Plasma corticosterone and ACTH concentrations were elevated by 2-fold to 3-fold in DL versus N, DP, and DV rats. In the pars distalis, glucocorticoid receptor (GR) mRNA levels were significantly higher in DL and DP rats compared with N and DV rats. Our results suggest that partial restoration of physiologic leptin: (1) successfully reduces hyperphagia while allowing body weight gain in STZ-diabetic rats; (2) increases corticosterone levels in STZ-diabetic rats, which may in turn counteract the anorexic effects of diabetes; and (3) is associated with increased pituitary GR mRNA levels, despite elevated corticosterone levels, suggesting that leptin may interfere with the negative feedback regulation of the HPA axis.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15562400</pmid><doi>10.1016/j.metabol.2004.06.024</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-0495
ispartof Metabolism, clinical and experimental, 2004-12, Vol.53 (12), p.1558-1564
issn 0026-0495
1532-8600
language eng
recordid cdi_proquest_miscellaneous_67107445
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adrenocorticotropic Hormone - blood
Animals
Biological and medical sciences
Blood Glucose
Body Weight - drug effects
Corticosterone - blood
Diabetes Mellitus, Experimental - blood
Diabetes Mellitus, Experimental - complications
Diabetes Mellitus, Experimental - metabolism
Diabetes. Impaired glucose tolerance
Eating - drug effects
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Epinephrine - blood
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Hyperphagia - blood
Hyperphagia - drug therapy
Hyperphagia - etiology
Hypothalamo-Hypophyseal System - drug effects
Hypothalamo-Hypophyseal System - metabolism
Insulin - blood
Leptin - pharmacology
Male
Medical sciences
Mice
Norepinephrine - blood
Pituitary-Adrenal System - drug effects
Pituitary-Adrenal System - metabolism
Pro-Opiomelanocortin - biosynthesis
Rats
Rats, Sprague-Dawley
Receptors, Glucocorticoid - biosynthesis
Recombinant Proteins - pharmacology
RNA, Messenger - biosynthesis
title Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T22%3A17%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Partial%20leptin%20restoration%20increases%20hypothalamic-pituitary-adrenal%20activity%20while%20diminishing%20weight%20loss%20and%20hyperphagia%20in%20streptozotocin%20diabetic%20rats&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=Akirav,%20Eitan%20M.&rft.date=2004-12-01&rft.volume=53&rft.issue=12&rft.spage=1558&rft.epage=1564&rft.pages=1558-1564&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/j.metabol.2004.06.024&rft_dat=%3Cproquest_cross%3E67107445%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67107445&rft_id=info:pmid/15562400&rft_els_id=S0026049504002793&rfr_iscdi=true